Antibody-breeding" has provided therapeutic/diagnostic antibody mutants with greater performance than native antibodies. typically, random point mutations are introduced into the V H and V L domains of parent antibodies to generate diverse libraries of single-chain fv fragments (scfvs), from which evolved mutants are selected. We produced an scFv against estradiol-17β with 11 amino acid substitutions and a >100-fold improved affinity constant (K a = 1.19 × 10 10 M −1 ) over the parent scfv, enabling immunoassays with >30-fold higher sensitivity. We systematically analyzed contributions of these substitutions to the affinity enhancement. Comparing various partial scFv revertants based on their K a s indicated that a revertant with four substitutions (V H -L100gQ, V L -I29V, -L36M, -S77G) exhibited somewhat higher affinity (K a = 1.46 × 10 10 M −1 ). finally, the V H -L100gQ substitution, occurring in V H complementarity-determining region (CDR) 3, was found to be the highest-priority for improving the affinity, and V L -I29V and/or V L -L36M cooperated significantly. These findings encouraged us to reconsider the potential of V H -CDR3-targeting mutagenesis, which has been frequently attempted. the substitution(s) wherein might enable a "high rate of return" in terms of selecting mutants with dramatically enhanced affinities. The "high risk" of generating a tremendous excess of "junk mutants" can be overcome with the efficient selection systems that we developed. substitution gained 10-fold higher affinity (based on the calculated equilibrium affinity constant K a ), whereas the anti-E 2 scFv with 11 substitutions exhibited a K a that was increased (improved) by >100-fold. The scFv mutants against cortisol and cotinine showed intermediate improvement, exhibiting >30-fold and >40-fold higher K a s as the results of three and five substitutions, respectively. However, a reasonable explanation for such correlations requires evidence that most or many (if not all) of these multiple substitutions participated in increasing the affinity to at least some extent.Regarding the positions of the substitution(s), a remarkable difference was found between the anti-cortisol scFvs (only in the V L ) and the anti-THC (only in the V H ) (Fig. 1). In contrast, with the anti-E 2 and anti-cotinine scFvs that showed more significant improvements, the substitutions were spread over both the V H and V L domains. The most successful example of in vitro affinity maturation for an antibody against a small compound was reported for an scFv against fluorescein derivative (K a > 1 × 10 12 M −1 ), which represented an affinity increase of>2,000-fold 19 . This "super" mutant, which is almost beyond native antibodies, was the product of 14 different substitutions, 12 of which were located in the V H domain ( Supplementary Fig. S1A).Recently, some approaches have been developed for improving antibody functions via computational analysis, in order to minimize the trial and error that is an inevitable aspect of the conventional strategies 20-23 . H...